oleanolic acid has been researched along with Sarcoma, Synovial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, BF; Feng, ZW; Gao, YX; Guo, DD; Lian, JJ; Ma, SP; Xue, H; Zhang, BB; Zhang, YP | 1 |
| Alemany, R; Barceló, F; Gómez-Florit, M; Martín-Broto, J; Martínez-Serra, J; Obrador-Hevia, A; Ruiz-Gutiérrez, V; Villar, VH; Vögler, O | 1 |
2 other study(ies) available for oleanolic acid and Sarcoma, Synovial
| Article | Year |
|---|---|
[Inhibitory effect of oleanolic acid on inflammatory response in IL-1β-stimulated human synovial sarcoma SW982 cells].
Topics: Anti-Inflammatory Agents; Cell Line; Cytokines; Extracellular Signal-Regulated MAP Kinases; Humans; I-kappa B Proteins; Inflammation; Interleukin-1beta; Matrix Metalloproteinase 1; NF-kappa B; NF-KappaB Inhibitor alpha; Oleanolic Acid; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Sarcoma, Synovial; Signal Transduction; Transcription Factor RelA | 2016 |
Oleanolic and maslinic acid sensitize soft tissue sarcoma cells to doxorubicin by inhibiting the multidrug resistance protein MRP-1, but not P-glycoprotein.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Glutathione; Humans; Multidrug Resistance-Associated Proteins; Oleanolic Acid; Sarcoma; Sarcoma, Synovial; Triterpenes | 2014 |